These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11006922)

  • 1. Complement activation in hypercholesterolemia.
    Pasqui AL; Bova G; Puccetti L; Bruni F; Pompella G; Auteri A
    Nutr Metab Cardiovasc Dis; 2000 Jun; 10(3):137-42. PubMed ID: 11006922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between serum complement and different lipid disorders.
    Pasqui AL; Puccetti L; Bova G; Di Renzo M; Bruni F; Pastorelli M; Palazzuoli A; Auteri A
    Clin Exp Med; 2002 May; 2(1):33-8. PubMed ID: 12049187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
    Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
    Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of the immune system in primary hypercholesterolaemia: effect of atorvastatin therapy.
    Sampietro T; Bigazzi F; Rossi G; Dal Pino B; Puntoni MR; Sbrana F; Chella E; Bionda A
    J Intern Med; 2005 Jun; 257(6):523-30. PubMed ID: 15910556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth muscle cell proliferation.
    Verdeguer F; Castro C; Kubicek M; Pla D; Vila-Caballer M; Vinué A; Civeira F; Pocoví M; Calvete JJ; Andrés V
    Cardiovasc Res; 2007 Nov; 76(2):340-50. PubMed ID: 17673191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair.
    Fiane AE; Videm V; Lingaas PS; Heggelund L; Nielsen EW; Geiran OR; Fung M; Mollnes TE
    Circulation; 2003 Aug; 108(7):849-56. PubMed ID: 12900342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation in acute coronary syndromes.
    Iltumur K; Karabulut A; Toprak G; Toprak N
    APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of serum complement and of circulating immune complexes in patients with multiple sclerosis.
    Cojocaru M; Serbănescu A; Cojocaru IM
    Rom J Intern Med; 1993; 31(2):131-7. PubMed ID: 8268831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of atorvastatin treatment on lipid profile and adhesion molecule levels in hypercholesterolemic patients: relation to low-density lipoprotein receptor gene polymorphism.
    Bolewski A; Lipiecki J; Plewa R; Burchardt P; Siminiak T
    Cardiology; 2008; 111(2):140-6. PubMed ID: 18376126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of plasma terminal SC5b-9 complement complex in patients with pregnancy induced hypertension].
    Shangguan B; Huang X; Zhang C
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):409-11. PubMed ID: 11360651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
    Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Improvement of endothelial function in patients with hypercholesterolemia and normal coronary arteries with lipid-lowering therapy].
    Iràculis E; Cequier A ; Sabaté M; Pintó X; Antoni Gómez-Hospital J; Mauri J; García Del Blanco B; Fernández-Nofrerias E; Palom X; Jara F; Esplugas E
    Rev Esp Cardiol; 2001 Jun; 54(6):685-92. PubMed ID: 11412774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of reduced plasma HDL subfractions in patients with cutaneous discoid lupus erythematosus.
    Lagogianni I; Papapanagiotou A; Piperi C; Kalofoutis C; Troupis G; Zachari A; Kalofoutis A
    Clin Biochem; 2005 Mar; 38(3):286-90. PubMed ID: 15708553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there any relationship between lipids and vitamin B levels in persons with elevated risk of atherosclerosis?
    Wasilewska A; Narkiewicz M; Rutkowski B; Łysiak-Szydłowska W
    Med Sci Monit; 2003 Mar; 9(3):CR147-51. PubMed ID: 12640345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The difference between serum and plasma complement activity in primary renal disease.
    Akagaki Y; Fujiwara Y; Nakanishi I; Orita Y; Ando A; Abe H; Kitamura H; Nagaki K; Inai S
    Clin Nephrol; 1980 Aug; 14(2):75-80. PubMed ID: 7408259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia.
    Pirro M; Schillaci G; Paltriccia R; Bagaglia F; Menecali C; Mannarino MR; Capanni M; Velardi A; Mannarino E
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2530-5. PubMed ID: 16946129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries.
    Niculescu F; Hugo F; Rus HG; Vlaicu R; Bhakdi S
    Clin Exp Immunol; 1987 Aug; 69(2):477-83. PubMed ID: 3652536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circulating immune complex and complement (C3) in a course of pulmonary tuberculosis].
    Dubaniewicz A; Sztaba-Kania M
    Pol Merkur Lekarski; 2002 Jun; 12(72):491-5. PubMed ID: 12362668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.